£55.90

It has never been this cheap. We have no record of a lower price.

£56 today · cheaper than every other day in the last 3 months

GRIN Verlag Untersuchungen zur Wirkung von KP 735 auf das klonogene Wachstum maligner frisch explantierter humaner Tumorzellen in vitro

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 39 days · 39 data points (no recent data)

Historical
Generating forecast…
£55.90 £53.11 £54.22 £55.34 £56.46 £57.58 £58.70 22 August 2026 31 August 2026 10 September 2026 19 September 2026 29 September 2026
View at Amazon ↗

9783640331055

Price data last checked 52 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 39 days • 1 price levels

Days at Price
39 days 0 10 20 29 39 £56 Days at Price

Price Analysis

Most common price: £56 (39 days, 100.0%)

Price range: £56 - £56

Price levels: 1 different prices over 39 days

Description

Doktorarbeit / Dissertation aus dem Jahr 1997 im Fachbereich Medizin - Neoplasmen, Onkologie, Note: 2, Technische Universität München, Sprache: Deutsch, Abstract: Im Rahmen der Dissertationsarbeit wurden Untersuchungen zur Wirkung von cis-Diammin-[(bis(phosphonatomethyl)amino)acetato(2-)-O1,N1]platin(II) (KP 735) auf das klonogene Wachstum maligner frisch explantierter humaner Tumorzellen in vitro durchgeführt. KP 735 ist eine technisch synthetisierte, phosphonsäure-gekoppelte Platinverbindung. Die antiproliferative Wirkung von KP 735 auf die Kolonienbildung von 74 frisch explantierten humanen Primärtumoren wurde mittels eines für klonogene Zellen selektiven kapillären Weichagarklonierungsverfahrens untersucht. Die Endkonzentrationen von KP 735 betrugen 10,0 µg/ml, 1,0 µg/ml und 0,1 µg/ml in der Langzeitexposition, sowie 100,0 µg/ml, 10,0 µg/ml, 1,0 µg/ml, 0,4 µg/ml, 0,32 µg/ml, und 0,1 µg/ml in der 1h-Exposition. In der kontinuierlichen Exposition waren 53 von 74 (72%) auswertbaren Proben ausreichend gewachsen, in der Kurzzeitexposition 51 von 74 (69%). KP 735 hemmte das klonogene Wachstum der Tumorzellen Konzentrations- und Expositionszeit-abhängig. In der Langzeitexposition wurden 32 von 53 Proben (60%) bei 10,0 µg/ml, 10 von 53 (19%) bei 1,0 µg/ml und 1 von 53 (2%) bei 0,1 µg/ml KP 735 gehemmt. In der Kurzzeitexposition hemmte KP 735 in einer Konzentration von 100,0 µg/ml 30 von 51 (59%), bei 10,0 µg/ml 15 von 51 (29%), bei 1,0 µg/ml 6 von 51 (12%), bei 0,40 µg/ml 3 von 51 (6%), bei 0,32 µg/ml 0 von 51 (0%), bei 0,10 µg/ml 1 von 51 (2%) der Proben. Cis-Diammin-[(bis(phosphonatomethyl)amino)acetato(2-)-O1,N1]platin(II), (KP 735) is a new platinum based agent wich has shown antitumor activity in established tumor cell lines. We have studied the effects of KP 735 on soft agar colony formation of freshly explanted human tumors in vitro and found antineoplastic activity.

Key Features

Used Book in Good Condition

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
09 June 2009
Listed Since
23 March 2010

Barcode

No barcode data available

Similar Products You Might Like

Cisplatin: Pharmacology, Clinical Uses & Adverse Effects (Pharmacology - Research, Safety Testing and Regulation: Cancer Etiology, Diagnosis and Treatments)
77% match

Cisplatin: Pharmacology, Clinical Uses & Adverse Effects (Pharmacology - Research, Safety Testing and Regulation: Cancer Etiology, Diagnosis and Treatments)

£86.54 14 Sep 2026
Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2
76% match

Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2

Springer

£147.76 24 Oct 2026
Anti-Cancer N-Heterocyclic Carbene Complexes of Gold(III), Gold(I) and Platinum(II): Thiol “Switch-on” Fluorescent Probes, Thioredoxin Reductase ... Reticulum Targeting Agents (Springer Theses)
76% match

Anti-Cancer N-Heterocyclic Carbene Complexes of Gold(III), Gold(I) and Platinum(II): Thiol “Switch-on” Fluorescent Probes, Thioredoxin Reductase ... Reticulum Targeting Agents (Springer Theses)

Springer

£75.60 24 Oct 2026
Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)
76% match

Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)

Springer

£107.85 24 Oct 2026
Predictive Drug Testing on Human Tumor Cells: 94 (Recent Results in Cancer Research, 94)
75% match

Predictive Drug Testing on Human Tumor Cells: 94 (Recent Results in Cancer Research, 94)

Springer

£78.02 15 Sep 2026
Ruthenium and Other Non-Platinum Metal Complexes in Cancer Chemotherapy: 10 (Progress in Clinical Biochemistry and Medicine, 10)
75% match

Ruthenium and Other Non-Platinum Metal Complexes in Cancer Chemotherapy: 10 (Progress in Clinical Biochemistry and Medicine, 10)

Springer

£110.08 25 Oct 2026
Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy: Molecular Mechanisms and Clinical Applications (Cancer Drug Discovery and Development)
75% match

Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy: Molecular Mechanisms and Clinical Applications (Cancer Drug Discovery and Development)

Humana

£146.56 21 Oct 2026
Checkpoint Controls and Targets in Cancer Therapy (Cancer Drug Discovery and Development)
75% match

Checkpoint Controls and Targets in Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£108.01 15 Sep 2026
Complications of Cancer Chemotherapy: Proceedings of the Plenary Sessions of E.O.R.T.C., Paris, June 1973: 49 (Recent Results in Cancer Research, 49)
75% match

Complications of Cancer Chemotherapy: Proceedings of the Plenary Sessions of E.O.R.T.C., Paris, June 1973: 49 (Recent Results in Cancer Research, 49)

Springer

£78.01 14 Sep 2026
Protein Kinase C in Cancer Signaling and Therapy (Current Cancer Research)
74% match

Protein Kinase C in Cancer Signaling and Therapy (Current Cancer Research)

Humana

£144.57 14 Nov 2026
Quatroammonimuplatinate and Anticancer Chemistry of Platinum via DFI
74% match

Quatroammonimuplatinate and Anticancer Chemistry of Platinum via DFI

VDM Verlag

£63.00 15 Sep 2026
Metallo-Drugs: Development and Action of Anticancer Agents (Metal Ions in Life Sciences): 18
74% match

Metallo-Drugs: Development and Action of Anticancer Agents (Metal Ions in Life Sciences): 18

De Gruyter

£180.00 14 Sep 2026
Horizons in Cancer Research: Volume 78 (Horizons in Cancer Research)
74% match

Horizons in Cancer Research: Volume 78 (Horizons in Cancer Research)

£170.39 16 Nov 2026
Towards Dual and Targeted Cancer Therapy with Novel Phthalocyanine-based Photosensitizers (Springer Theses)
74% match

Towards Dual and Targeted Cancer Therapy with Novel Phthalocyanine-based Photosensitizers (Springer Theses)

Springer

£75.96 24 Oct 2026
Generation of Novel Human Cancer Vaccine: Testing in phase III clinical trials
74% match

Generation of Novel Human Cancer Vaccine: Testing in phase III clinical trials

LAP Lambert Academic Publishing

£42.00 14 Sep 2026
Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models
74% match

Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models

Springer

£73.95 15 Sep 2026
Cytokines in the Genesis and Treatment of Cancer (Cancer Drug Discovery and Development)
74% match

Cytokines in the Genesis and Treatment of Cancer (Cancer Drug Discovery and Development)

Humana

£148.47 03 Nov 2026
Natural Products and Cancer Drug Discovery (Cancer Drug Discovery and Development)
74% match

Natural Products and Cancer Drug Discovery (Cancer Drug Discovery and Development)

Humana

£109.35 22 Oct 2026
Hypoxie und Strahlentherapie: Einfluss synthetischer und natürlicher HIF-Modulatoren auf Wachstum & Strahlensensibilität von humanen Tumorzellen
74% match

Hypoxie und Strahlentherapie: Einfluss synthetischer und natürlicher HIF-Modulatoren auf Wachstum & Strahlensensibilität von humanen Tumorzellen

Südwestdeutscher Verlag für Hochschulschriften

£48.00 14 Sep 2026
Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models
74% match

Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models

Springer

£75.96 26 Oct 2026
Pathobiology of Human Germ Cell Neoplasia: 123 (Recent Results in Cancer Research, 123)
74% match

Pathobiology of Human Germ Cell Neoplasia: 123 (Recent Results in Cancer Research, 123)

Springer

£113.93 27 Oct 2026
New Approaches in Cancer Pharmacology: Drug Design and Development: Vol. II: 2 (ESO Monographs)
74% match

New Approaches in Cancer Pharmacology: Drug Design and Development: Vol. II: 2 (ESO Monographs)

Springer

£78.01 24 Oct 2026
Molecular and Cellular Biology of Multidrug Resistance in Tumour Cells
74% match

Molecular and Cellular Biology of Multidrug Resistance in Tumour Cells

Springer

£67.00 04 Nov 2026
Biology and Management of Lung Cancer: 11 (Cancer Treatment and Research)
74% match

Biology and Management of Lung Cancer: 11 (Cancer Treatment and Research)

Springer

£158.19 24 Oct 2026